Aphria Inc.

14.84+0.8900+6.38%Vol 17.56M1Y Perf 326.22%
Apr 13th, 2021 15:06 DELAYED
BID14.84 ASK14.85
Open13.23 Previous Close13.95
Pre-Market- After-Market-
 - -%  - -
Target Price
12.72 
Analyst Rating
Moderate Buy 1.63
Potential %
-14.00 
Finscreener Ranking
★★★+     52.37
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★     48.05
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★+     44.00
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap4.70B 
Earnings Rating
Strong Sell
Price Range Ratio 52W %
40.87 
Earnings Date
12th Apr 2021

Today's Price Range

13.0315.05

52W Range

2.7832.29

5 Year PE Ratio Range

-44.20871.80

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-19.32%
1 Month
-30.25%
3 Months
39.50%
6 Months
128.69%
1 Year
326.22%
3 Years
54.66%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
APHA14.840.89006.38
AAPL134.283.04002.32
GOOG2 271.2816.49000.73
MSFT258.292.38000.93
XOM55.710.21000.38
WFC39.93-0.8400-2.06
JNJ159.46-2.1800-1.35
FB311.46-0.0800-0.03
GE13.50-0.0900-0.66
JPM154.93-1.0200-0.65
Financial StrengthValueIndustryS&P 500US Markets
1.00
2.40
0.22
0.29
-6.40
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
39.80
-33.40
-23.90
7.20
-50.74
RevenueValueIndustryS&P 500US Markets
364.89M
1.15
145.70
147.83
Earnings HistoryEstimateReportedSurprise %
Q03 2021-0.12-0.21-75.00
Q02 2021-0.06-0.0350.00
Q01 2021-0.03-0.0166.67
Q04 2020-0.03-0.10-233.33
Q03 2020-0.040.02150.00
Q02 2020-0.02-0.020.00
Q01 2020-0.030.00100.00
Q04 2019-0.050.00100.00
Earnings Per EndEstimateRevision %Trend
2/2021 QR-0.03-200.00Negative
5/2021 QR-0.01--
5/2021 FY-0.22-266.67Negative
5/2022 FY0.05-28.57Negative
Next Report Date-
Estimated EPS Next Report-0.03
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume17.56M
Shares Outstanding316.80M
Trades Count113.22K
Dollar Volume390.62M
Avg. Volume23.74M
Avg. Weekly Volume15.08M
Avg. Monthly Volume12.85M
Avg. Quarterly Volume24.74M

Aphria Inc. (NYSE: APHA) stock closed at 13.95 per share at the end of the most recent trading day (a -14.31% change compared to the prior day closing price) with a volume of 26.88M shares and market capitalization of 4.70B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 1200 people. Aphria Inc. CEO is Irwin D. Simon.

The one-year performance of Aphria Inc. stock is 326.22%, while year-to-date (YTD) performance is 101.59%. APHA stock has a five-year performance of %. Its 52-week range is between 2.78 and 32.29, which gives APHA stock a 52-week price range ratio of 40.87%

Aphria Inc. currently has a PE ratio of -25.30, a price-to-book (PB) ratio of 3.43, a price-to-sale (PS) ratio of 12.11, a price to cashflow ratio of 2 681.60, a PEG ratio of 2.32, a ROA of -8.03%, a ROC of -8.18% and a ROE of -11.76%. The company’s profit margin is -50.74%, its EBITDA margin is -23.90%, and its revenue ttm is $364.89 Million , which makes it $1.15 revenue per share.

Of the last four earnings reports from Aphria Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.03 for the next earnings report. Aphria Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Aphria Inc. is Moderate Buy (1.63), with a target price of $12.72, which is -14.00% compared to the current price. The earnings rating for Aphria Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Aphria Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Aphria Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 23.22, ATR14 : 2.52, CCI20 : -202.55, Chaikin Money Flow : -0.27, MACD : 0.21, Money Flow Index : 19.84, ROC : -20.06, RSI : 46.71, STOCH (14,3) : 2.59, STOCH RSI : 0.08, UO : 27.82, Williams %R : -97.41), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Aphria Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (62.50 %)
5 (62.50 %)
4 (50.00 %)
Moderate Buy
1 (12.50 %)
1 (12.50 %)
1 (12.50 %)
Hold
2 (25.00 %)
2 (25.00 %)
3 (37.50 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.63
Moderate Buy
1.63
Moderate Buy
1.88

Aphria Inc.

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewery. The company is focusing on expanding through international cultivation and distribution into the global medical cannabis market. Aphria also offers multiple products under a portfolio of recreational cannabis brands, including B!NGO, Solei, RIFF, and Broken Coast.

CEO: Irwin D. Simon

Telephone: +1 844 427-4742

Address: 98 Talbot Street West, Leamington N8H 1M8, ON, CA

Number of employees: 1 200

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

67%33%

Bearish Bullish

56%44%

Bearish Bullish

55%45%

Bearish Bullish

54%46%

News

Stocktwits